蓝驰创投
@author-1783936746940
不被定义
Articles
BlueRun Ventures Quarterly Investment & Financing Overview | 2023 Q4
Sector distribution spans artificial intelligence, enterprise services, hard tech, and biotech, among others.
BlueRun Ventures and Its Portfolio Companies Win Multiple Awards from Forbes China, TMTpost, Jiemian News, and Cyzone
Standing alongside founders from zero to one to redefine the future.
BlueRun Ventures | With continued backing from BlueRun Ventures, UniUni closes $20 million Series B2 round
North America's Next-Generation Last-Mile Delivery Leader
BlueRun Ventures and Its Portfolio Companies Win Multiple Awards from Jazzyear, TMTpost, China FOF Research Center, and ChinaVenture
Partnering with founders from zero to one to redefine the future.
BlueRun Ventures | BlueRun Ventures Leads PowerLaw AI's Nearly RMB 80 Million Pre-B Round
Continuously exploring the boundaries of large language model capabilities and new legal service models
Looking at the Other Side of the Coin | October & November Report
Grateful for what life has given
BlueRun Ventures | With Continued Backing from BlueRun Ventures, Don Quijote Closes 100 Million Yuan Series B Round
Dedicated to becoming a full-stack digital construction collaboration platform for the next generation of chain retail businesses.
Remembering Charlie Munger | BlueRun Ventures
"Taking the broad road is the mark of true wisdom."
BlueRun Ventures' Jui Chan Named to ChinaVenture's Top 50 Early-Stage Investors and Top 3 Angel Investors
Deep Tech, Investing in the Future
BlueRun Ventures | BlueRun Ventures Continues to Double Down, Zhitai Bio Closes Nearly RMB 200 Million Series B+ Round
Focused on developing recombinant protein therapeutics using an *E. coli*-based technology platform.